UNLABELLED: This study of 170 children in the Czech Republic examines the clinical course and sequelae for tick-borne encephalitis. Evaluated were demographic and epidemiological data, signs and symptoms at admission, clinical course during hospital stay and laboratory findings. Cerebrospinal fluid was analysed for white blood cells, protein, impairment of blood-cerebrospinal fluid (CSF) barrier and tick-borne encephalitis virus (TBEV)-specific antibodies. Subjective complaints and objective neurological deficits were investigated. Tick bites were reported in 74 % of the children. The illness had a biphasic clinical course in 58 % of cases. The second phase was characterized by headache in 98 %, high fever in 86 % (more than 38.5 °C), vomiting in 64 % and meningeal signs in 92 % of children. Meningitis (77 %) dominated over meningoencephalitis (13 %). Inflammatory changes in CSF were found in 90 % of children. Immunoglobulin M (IgM) antibodies against TBEV in serum were found early in the infection in 99 %. IgM positivity lasted up to 1,126 days. Neurocognitive abnormalities were found in 19 (11 %) of children. Acquired aphasia, lasting tremor of the upper extremities, speech impairment, inversion of sleep and wakefulness, abnormal hyperkinetic movements and vertigo were found to be permanent but not progressing. Severe sequelae persisted in two children (1 %) while in three (2 %) were classified as mild or moderate. CONCLUSION: Tick-borne encephalitis in children has a benign course with minimal sequelae. Meningitis with biphasic course is the prevalent involvement and the duration of IgM antibodies in serum and index of positivity are not decisive for postencephalitic disorders.

Department of Children's Infectious Diseases Faculty of Medicine and University Hospital Masaryk University Jihlavská 100 62500 Brno Czech Republic

Zobrazit více v PubMed

Pediatrics. 2010 Oct;126(4):e828-35 PubMed

Acta Paediatr. 2008 May;97(5):535-8 PubMed

Int J Med Microbiol. 2006 May;296 Suppl 40:76-9 PubMed

J Neurol. 1997 Apr;244(4):230-8 PubMed

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):623-6 PubMed

Scand J Infect Dis. 1998;30(5):509-12 PubMed

Clin Infect Dis. 2002 Sep 15;35(6):650-8 PubMed

Pediatr Infect Dis J. 2012 Jun;31(6):570-4 PubMed

Vaccine. 2010 Apr 1;28(16):2827-31 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:30-3 PubMed

Wien Med Wochenschr. 2012 Jun;162(11-12):230-8 PubMed

Vaccine. 2003 Apr 1;21 Suppl 1:S3-S10 PubMed

Wien Med Wochenschr. 2012 Jun;162(11-12):239-43 PubMed

Clin Infect Dis. 1999 Apr;28(4):882-90 PubMed

J Gen Virol. 2009 Aug;90(Pt 8):1781-1794 PubMed

Vaccine. 2010 Oct 28;28(46):7396-400 PubMed

J Neurol Neurosurg Psychiatry. 2006 Dec;77(12):1350-3 PubMed

Ticks Tick Borne Dis. 2010 Sep;1(3):129-40 PubMed

Clin Microbiol Infect. 2012 Oct;18(10):1027-32 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:6-10 PubMed

Brain. 1999 Nov;122 ( Pt 11):2067-78 PubMed

J Pediatr. 2013 Aug;163(2):555-60 PubMed

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):636-40 PubMed

Lancet. 2008 May 31;371(9627):1861-71 PubMed

Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):98-103 PubMed

Ticks Tick Borne Dis. 2011 Mar;2(1):2-15 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:58-61 PubMed

Acta Med Croatica. 2005;59(4):347-52 PubMed

Scand J Infect Dis. 1996;28(3):217-24 PubMed

Wien Klin Wochenschr. 1999 Jun 18;111(12):484-7 PubMed

J Child Neurol. 2005 Jun;20(6):500-8 PubMed

Eur J Pediatr. 2005 Dec;164(12):787-8 PubMed

CNS Drugs. 2005;19(12):1009-32 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:50-4 PubMed

Infection. 2000 Mar-Apr;28(2):74-7 PubMed

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):627-9 PubMed

Pediatr Infect Dis J. 2003 Jul;22(7):612-7 PubMed

Infection. 2000 Mar-Apr;28(2):78-84 PubMed

Vector Borne Zoonotic Dis. 2012 Jun;12(6):496-502 PubMed

Eur J Pediatr. 2012 Feb;171(2):347-52 PubMed

Vaccine. 2003 Apr 1;21 Suppl 1:S11-8 PubMed

Clin Infect Dis. 1993 Mar;16(3):392-6 PubMed

Pediatr Infect Dis J. 2005 Oct;24(10):892-6 PubMed

Emerg Infect Dis. 2013 Jan;19(1):69-76 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:43-7 PubMed

Vaccine. 2007 Oct 23;25(43):7559-67 PubMed

Pediatr Infect Dis J. 2011 Apr;30(4):355-7 PubMed

MMW Munch Med Wochenschr. 1976 Dec 3;118(49):1609-12 PubMed

Pediatr Infect Dis J. 2007 Feb;26(2):185-6 PubMed

Eur J Pediatr. 1992 Oct;151(10):743-4 PubMed

Int J Med Microbiol. 2002 Jun;291 Suppl 33:48-9 PubMed

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients

Tick-Borne Encephalitis in an 8.5-Month-Old Boy Suspected of Febrile Seizures

Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017